OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany
WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organization in Germany.
Expanding Commitment
OrthoPediatrics GmbH commenced operations on January 1, 2023, marking the Company’s first direct international organization. This move represents OrthoPediatrics’ commitment to expanding its presence in the global market and providing specialized orthopedic solutions to pediatric patients in Germany.
By establishing a direct sales organization in Germany, OrthoPediatrics aims to streamline its operations, improve customer service, and enhance its ability to meet the unique needs of pediatric orthopedic surgeons and their patients in the region. The decision to establish OrthoPediatrics GmbH reflects the Company’s dedication to advancing the field of pediatric orthopedics and delivering innovative, high-quality products to healthcare professionals worldwide.
Impact on Individuals
For healthcare professionals and pediatric patients in Germany, the establishment of OrthoPediatrics GmbH will likely result in improved access to cutting-edge orthopedic solutions specifically designed for children. With a direct sales organization in the region, healthcare providers can expect enhanced support, training, and resources to help them effectively treat pediatric orthopedic conditions.
Pediatric patients in Germany stand to benefit from OrthoPediatrics’ focus on developing innovative orthopedic implants and instruments tailored to their unique anatomical needs. By expanding its presence in the country, OrthoPediatrics is demonstrating its commitment to improving outcomes and quality of life for children with orthopedic disorders.
Global Impact
On a global scale, OrthoPediatrics’ establishment of a direct sales organization in Germany underscores the growing importance of specialized pediatric orthopedic care. By expanding its international presence, OrthoPediatrics is better positioned to collaborate with healthcare providers, researchers, and industry partners around the world to advance the field of pediatric orthopedics.
Furthermore, OrthoPediatrics’ continued focus on innovation and commitment to excellence in pediatric orthopedics sets a precedent for other medical device companies seeking to improve outcomes for pediatric patients. The Company’s dedication to serving the unique needs of children with orthopedic conditions may inspire broader advancements in pediatric healthcare and contribute to the development of new and improved treatment options globally.
Conclusion
In conclusion, the establishment of OrthoPediatrics GmbH in Germany represents a significant milestone for the Company and a positive development for healthcare professionals, pediatric patients, and the global orthopedic community. By expanding its direct sales organization to Germany, OrthoPediatrics is reaffirming its commitment to advancing pediatric orthopedics and improving outcomes for children with orthopedic conditions worldwide.
